|
US6750325B1
(en)
|
1989-12-21 |
2004-06-15 |
Celltech R&D Limited |
CD3 specific recombinant antibody
|
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
US7381803B1
(en)
|
1992-03-27 |
2008-06-03 |
Pdl Biopharma, Inc. |
Humanized antibodies against CD3
|
|
GB9524973D0
(en)
|
1995-12-06 |
1996-02-07 |
Lynxvale Ltd |
Viral vectors
|
|
US7112324B1
(en)
|
1998-04-21 |
2006-09-26 |
Micromet Ag |
CD 19×CD3 specific polypeptides and uses thereof
|
|
WO2004016740A2
(en)
|
2002-08-15 |
2004-02-26 |
Epitomics, Inc. |
Humanized rabbit antibodies
|
|
JP3803790B2
(ja)
|
2003-02-17 |
2006-08-02 |
株式会社東北テクノアーチ |
新規なダイアボディ型二重特異性抗体
|
|
AU2003259718A1
(en)
|
2003-08-07 |
2005-03-07 |
Epitomics, Inc. |
Methods for humanizing rabbit monoclonal antibodies
|
|
MXPA06004035A
(es)
|
2003-10-16 |
2006-08-31 |
Micromet Ag |
Aglutinantes cd3 de-inmunizados multi-especificos.
|
|
CA2569509C
(en)
|
2004-06-03 |
2014-08-12 |
Novimmune S.A. |
Anti-cd3 antibodies and methods of use thereof
|
|
JP4902674B2
(ja)
|
2006-03-09 |
2012-03-21 |
エフ．ホフマン−ラ ロシュ アーゲー |
抗薬物抗体アッセイ法
|
|
CA2673470A1
(en)
|
2006-12-21 |
2008-07-03 |
Macrogenics, Inc. |
Methods for the treatment of lada and other adult-onset autoimmune diabetes using immunosuppressive monoclonal antibodies with reduced toxicity
|
|
RU2009137582A
(ru)
|
2007-03-12 |
2011-04-20 |
Эсбатек Аг (Ch) |
Инженерия и оптимизация одноцепочечных антител на основе последовательности
|
|
RS53008B2
(sr)
|
2007-04-03 |
2022-12-30 |
Amgen Res Munich Gmbh |
Interspecijski specifičan cd3-epsilon vezujući domen
|
|
KR20170036814A
(ko)
|
2007-05-21 |
2017-04-03 |
앨더바이오 홀딩스 엘엘씨 |
신규한 래빗 항체 인간화 방법 및 인간화된 래빗 항체
|
|
BRPI0813645A2
(pt)
|
2007-06-25 |
2014-12-30 |
Esbatech Alcon Biomed Res Unit |
Métodos para modificar anticorpos, e anticorpos modificados com propriedades funcionais aperfeiçoadas
|
|
EP2164961B1
(en)
|
2007-06-25 |
2015-01-07 |
ESBATech, an Alcon Biomedical Research Unit LLC |
Sequence based engineering and optimization of single chain antibodies
|
|
CA2728829C
(en)
|
2008-06-25 |
2018-01-02 |
Esbatech, An Alcon Biomedical Research Unit Llc |
Solubility optimization of immunobinders
|
|
PL2307458T3
(pl)
|
2008-06-25 |
2018-08-31 |
Esbatech, An Alcon Biomedical Research Unit Llc |
Humanizacja przeciwciał króliczych z zastosowaniem uniwersalnego zrębu przeciwciała
|
|
KR102211837B1
(ko)
|
2013-01-14 |
2021-02-03 |
젠코어 인코포레이티드 |
신규한 이형이량체 단백질
|
|
JP6594855B2
(ja)
|
2013-03-15 |
2019-10-23 |
ゼンコア インコーポレイテッド |
ヘテロ二量体タンパク質
|
|
IL263466B2
(en)
|
2013-12-17 |
2023-10-01 |
Genentech Inc |
Anti-CD3 antibodies and methods of using them
|
|
WO2015123315A1
(en)
|
2014-02-11 |
2015-08-20 |
Genzyme Corporation |
Assays for detecting the presence or amount of an anti-drug antibody
|
|
PE20171324A1
(es)
|
2014-11-26 |
2017-09-11 |
Xencor Inc |
Anticuerpos heterodimericos que se unen a cd3 y a antigenos tumorales
|
|
US12480957B2
(en)
|
2017-03-31 |
2025-11-25 |
Ablynx N.V. |
Method of screening for anti-drug antibodies against immunoglobulin single variable domain-based drugs
|
|
LT3428194T
(lt)
*
|
2017-07-14 |
2021-12-10 |
Immatics Biotechnologies Gmbh |
Pagerinta dvejopo savitumo polipeptido molekulė
|
|
WO2019195535A1
(en)
|
2018-04-05 |
2019-10-10 |
Novartis Ag |
Trispecific binding molecules against cancers and uses thereof
|
|
KR20220015382A
(ko)
*
|
2019-05-29 |
2022-02-08 |
큐 바이오파마, 인크. |
다량체 t-세포 조절 폴리펩타이드 및 이의 사용 방법
|
|
EP4025908A4
(en)
|
2019-09-05 |
2023-07-19 |
Adverum Biotechnologies, Inc. |
ANTI-DRUG ANTIBODY TEST
|
|
NL2024375B1
(en)
*
|
2019-12-04 |
2021-08-31 |
Apo T B V |
Methods and means for attracting immune effector cells to tumor cells.
|
|
IL293698A
(en)
*
|
2019-12-11 |
2022-08-01 |
Molecular Partners Ag |
Recombinant peptide-mhc complex binding proteins, their production and use
|
|
MX2023010541A
(es)
|
2021-03-09 |
2023-11-24 |
Cdr Life Ag |
Proteinas de union al antigeno del peptido del mhc mage-a4.
|
|
US12435444B2
(en)
|
2021-03-09 |
2025-10-07 |
Cdr-Life Ag |
Rabbit-derived antigen binding protein nucleic acid libraries and methods of making the same
|